Zinedin activators primarily engage with the extensive calcium signaling pathway, given STRN4's potential involvement in such processes. Agents like Forskolin, which elevates cAMP levels, and Phorbol 12-myristate 13-acetate (PMA), a known activator of PKC, can have downstream effects on calcium signaling that indirectly modulate STRN4 activity. Calcium ionophores and modulators, such as Ionomycin and Thapsigargin, respectively, are pivotal in raising intracellular calcium levels, a process that could influence STRN4 due to its prospective association with calcium signaling.
Moreover, chemicals like Okadaic acid and Calyculin A inhibit protein phosphatases, thus potentially altering protein phosphorylation landscapes, including that of STRN4. Calcium channel blockers and modifiers, such as Nifedipine and Ryanodine, can further refine the intricacies of calcium signaling, subsequently impacting STRN4. Furthermore, EGTA, a calcium chelator, and 2-APB, which modulates IP3 receptor activity, further highlight the deep-rooted association of calcium signaling with STRN4's cellular dynamics.
SEE ALSO...
Items 21 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|